Latest News about IMMU
Recent news which mentions IMMU
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
From Motley Fool
Gilead's New CEO Is Going All-In on Acquisitions
November 28, 2020
From Motley Fool
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO
October 23, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
October 22, 2020
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 21, 2020
From Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 20, 2020
From Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 19, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 16, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 14, 2020
From Benzinga
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
October 11, 2020
From Motley Fool
Is Gilead Sciences a Buy?
October 11, 2020
From Motley Fool
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
September 24, 2020
From Benzinga
The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
September 20, 2020
From Benzinga
ETF Wrap: How to think about – and play – the wave of M&A activity
September 17, 2020
From MarketWatch
From MarketWatch
Benzinga's Top Upgrades, Downgrades For September 15, 2020
September 15, 2020
From Benzinga
10 Biggest Price Target Changes For Tuesday
September 15, 2020
From Benzinga
The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO
September 15, 2020
From Benzinga
80 Biggest Movers From Yesterday
September 15, 2020
From Benzinga
Mid-Afternoon Market Update: Dow Rises 350 Points; Cassava Sciences Shares Spike Higher
September 14, 2020
From Benzinga
From Benzinga
60 Stocks Moving In Monday's Mid-Day Session
September 14, 2020
From Benzinga
Mid-Day Market Update: Immunomedics Jumps Following Acquisition News; Mallinckrodt Shares Slide
September 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
September 14, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 14, 2020
September 14, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.